The microbial metabolite desaminotyrosine protects from influenza through type I interferon
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Eat more plants for influenza resilience: Antibiotic treatment worsens influenza in mice, possibly because the concomitant loss of the microbiota interrupts the production of bioactive metabolites. Steed et al. found that a microbial product, desaminotyrosine (DAT), produced by an obligate clostridial anaerobe from the digestion of plant flavonoids, is beneficial during influenza. DAT enters the bloodstream and triggers type I interferon signaling, which then augments antiviral responses by phagocytic cells. Without DAT, influenza virus causes inflammation and severe disease. Science , this issue p. 498
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Desaminotyrosine, a product derived from the gut commensal Clostridium orbiscindens, exerts distal effects on the lung to protect against influenza through modulation of type I IFN signaling.220”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [220]
In the citing paper
“Antibiotic-treated mice exhibited markedly decreased fecal and serum DAT levels, which was associated with attenuated type I IFN responses to influenza infection and increased mortality”
From Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia. (2018) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
Host-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760
Gut Microbiota Metabolism of Dietary Fiber Influences Allergic Airway Disease and Hematopoiesis
Trompette, A., Gollwitzer, E. S., Yadava, K., Sichelstiel, A. K., Sprenger, N., Ngom-Bru, C., Blanchard, C., Junt, T., Nicod, L. P., Harris, N. L., et al. (2014) · Nature Medicine · doi:10.1038/nm.3444 · Cited by 2,862
Microbiota regulates immune defense against respiratory tract influenza A virus infection
Ichinohe, T., Pang, I. K., Kumamoto, Y., Peaper, D. R., Ho, J. H., Murray, T. S., & Iwasaki, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019378108 · Cited by 1,502
Cited by
Items 201–300 of 583
Runge, S., & Rosshart, S. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.702378 · Cited by 41
Microbial metabolites: cause or consequence in gastrointestinal disease?
Fobofou, S. A. T., & Savidge, T. (2022) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00008.2022 · Cited by 37
Yao, Z., Cao, Y.-N., Peng, L., Yan, Z., & Zhao, G. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c05691 · Cited by 38
Yang, Q.-Y., Yang, Y., Tang, Y., Qin, P., Gan, W., Xie, J., Chen, S., Ding, C., Huang, Y., & Zhu, S. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010620 · Cited by 36
“Cumulative evidence suggests a fundamental role of the microbial metabolites in regulating viral infections locally and systemically [3,4,33].”
BackgroundChen, T., Wu, H., He, Y., Pan, W., Yan, Z., Liao, Y., Peng, W., Gan, L., Zhang, Y., Su, W., et al. (2019) · Molecules · doi:10.3390/molecules24234287 · Cited by 36
“Considering the bioactivities of naringenin [19– 21] and HPPA [22], gut microbiota could in part play an important role in regulating the pharmacological effects of naringin through biotransformation in vivo.”
BackgroundZhou, P., Zou, Z., Wu, W., Zhang, H., Wang, S., Tu, X., Huang, W., Chen, C., Zhu, S., Weng, Q., et al. (2023) · BMC Microbiology · doi:10.1186/s12866-023-03078-3 · Cited by 38
“The gut microbiota regulates immune responses in mucous membranes and distant organs, including the lungs [12, 13].”
BackgroundPromising dawn in the management of pulmonary hypertension: The mystery veil of gut microbiota
Yang, Y., Zhang, H., Wang, Y., Xu, J., Shu, S., Wang, P., Ding, S., Huang, Y., Zheng, L., Yang, Y., et al. (2024) · iMeta · doi:10.1002/imt2.159 · Cited by 38
“In addition, the regulation roles of other gut microbiota ‐ related metabolites in the lung, including deaminated tryptophan [75]. are being discovered, which contributes to further knowledge of the gut – lung axis.”
BackgroundWang, Y., Qin, S., Jia, J., Huang, L., Li, F., Jin, F., Ren, Z., & Wang, Y. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01343 · Cited by 34
Shi, Y., Xu, H., Xiao, Y., Liu, P., Pang, P., Wu, S., Deng, L., & Chen, X. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109471 · Cited by 34
Tonic interferon restricts pathogenic IL-17-driven inflammatory disease via balancing the microbiome
Marié, I. J., Brambilla, L., Azzouz, D. F., Chen, Z., Baracho, G. V., Arnett, A., Li, H. S., Liu, W., Cimmino, L., Chattopadhyay, P. K., et al. (2021) · eLife · doi:10.7554/elife.68371 · Cited by 40
Phage therapy in the Covid-19 era: Advantages over antibiotics
Khan, A., Rao, T. S., & Joshi, H. (2022) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2022.100115 · Cited by 35
“According to Steed et al., microbiota-associated metabolites protect against influenza infection via type 1 interferon (Steed et al., 2017).”
Yin, H., Liu, Z., Zhang, W., Yang, Q., Yu, T., & Jiang, X. (2022) · Microbiome · doi:10.1186/s40168-022-01348-2 · Cited by 37
Links between fecal microbiota and the response to vaccination against influenza A virus in pigs
Borey, M., Blanc, F., Lemonnier, G., Leplat, J. J. J. J., Jardet, D., Rossignol, M., Ravon, L., Billon, Y., Bernard, M., Estellé, J., et al. (2021) · npj Vaccines · doi:10.1038/s41541-021-00351-2 · Cited by 36
Bacterial Gut Microbiota and Infections During Early Childhood
George, S., Aguilera, X., Gallardo, P., Farfán, M. J., Lucero, Y., Torres, J. P., Vidal, R. M., & O’Ryan, M. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.793050 · Cited by 36
The intestinal microbiota and improving the efficacy of COVID-19 vaccinations
Chen, J., Vitetta, L., Henson, J. D., & Hall, S. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104850 · Cited by 32
Ran, C., Li, Y., Ma, X., Xie, Y., Xie, M., Zhang, Y., Zhou, W., Yang, Y., Zhang, Z., Zhou, L., et al. (2021) · Science China Life Sciences · doi:10.1007/s11427-020-1721-5 · Cited by 33
Bypassing the Gut–Lung Axis via Microbial Metabolites: Implications for Chronic Respiratory Diseases
Bulanda, E., & Wypych, T. P. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.857418 · Cited by 34
Haldar, S., Jadhav, S. R., Gulati, V., Beale, D. J., Balkrishna, A., Varshney, A., Palombo, E. A., Karpe, A. V., & Shah, R. (2023) · FEMS Microbiology Ecology · doi:10.1093/femsec/fiad103 · Cited by 35
Kim, S., Lee, S., Kim, T.-Y., Lee, S.-H., Seo, S., & Kweon, M. (2023) · Microbiome · doi:10.1186/s40168-023-01687-8 · Cited by 33
Gut microbiota in antiviral strategy from bats to humans: a missing link in COVID-19
Luo, J., Shan, L., & Jin, F. (2021) · Science China Life Sciences · doi:10.1007/s11427-020-1847-7 · Cited by 33
Cheng, M., Zhang, Y., Yan, J., Huang, Y., Wang, M., Zhai, Z., Liu, G., Liu, C., Li, J., Zhang, Y., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116481 · Cited by 30
The human gut microbiome in critical illness: disruptions, consequences, and therapeutic frontiers
Sung, J., Rajendraprasad, S. S., Philbrick, K. L., Bauer, B. A., Gajic, O., Shah, A., Laudański, K., Bakken, J., Skalski, J. H., & Karnatovskaia, L. V. (2023) · Journal of Critical Care · doi:10.1016/j.jcrc.2023.154436 · Cited by 36
“[16–19] The heart isn’t exempt from the influence of our gut residents.”
BackgroundLiang, X., Zhang, Z., Wang, H., Lu, X., Li, W., Lu, H., Roy, A., Shen, X., Irwin, D. M., & Shen, Y. (2023) · Microbiome · doi:10.1186/s40168-023-01609-8 · Cited by 31
A Critical Review on the Role of Probiotics in Lung Cancer Biology and Prognosis
Ashique, S., Mishra, N., Garg, A., Kumar, N., Khan, Z., Mohanto, S., Chellappan, D. K., Farid, A., & Taghizadeh‐Hesary, F. (2024) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2024.04.030 · Cited by 30
Putative markers for the detection of early-stage bladder cancer selected by urine metabolomics
Lin, J., Juo, B.-R., Yeh, Y.-H., Fu, S.-H., Chen, Y., Chen, C., & Wu, K. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04235-z · Cited by 30
“The literature report about desaminotyrosine is scarce only suggesting a metabolite of the gut microbes related to the immune system [36].”
BackgroundLiu, X., Liu, J., Lei, D., & Zhao, G.-R. (2021) · Chemical Engineering Science · doi:10.1016/j.ces.2021.116931 · Cited by 29
Gut microbiota-derived metabolites as key mucosal barrier modulators in obesity
Wei, Y., Zheng, K., & Wang, Y.-G. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i33.5555 · Cited by 35
Early life gut microbiota: Consequences for health and opportunities for prevention
Wang, S., Cui, J., Jiang, S., Zheng, C., Zhao, J., Zhang, H., & Zhai, Q. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2158451 · Cited by 31
“These include overweight/ obesity, diabetes, respiratory tract infections, and growth retardation (Aversa et al. 2021; Wells et al. 2020; Cox et al. 2014; Steed et al. 2017; Gray et al. 2017; Reyman et al. 2019).”
BackgroundWhat we need to know about the germ-free animal models
Aghighi, F., & Salami, M. (2024) · AIMS Microbiology · doi:10.3934/microbiol.2024007 · Cited by 33
Microbiome modulation of tumorigenesis and immune responses
Chen, Y., Fang, Y., Lyu, Z., Tian, Y., Niu, S., Li, Y.-R., & Yang, L. (2026) · Journal of Biomedical Science · doi:10.1186/s12929-025-01208-9 · Cited by 30
“In contrast, the microbiota-derived metabolite des-aminotyrosine (DAT) confers protection against influenza infection by amplifying type I interferon signaling, thereby mitigating immunopathology in the lungs [113].”
Nagai, M., Moriyama, M., & Ichinohe, T. (2021) · mBio · doi:10.1128/mbio.01598-21 · Cited by 29
Microbiomes in the insectivorous bat species Mops condylurus rapidly converge in captivity
Edenborough, K. M., Mu, A., Mühldorfer, K., Lechner, J., Lander, A., Bokelmann, M., Couacy‐Hymann, E., Radonić, A., & Kurth, A. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0223629 · Cited by 28
“Enteric bacterial community structure is known to modulate viral infection severity in insects and mammals (reviewed in [11] and [12]) and has been shown to either promote or restrict infection for poliovirus [13], norovirus [14] and influenza [15].”
BackgroundInteractions Between Gut Microbiota and Hosts and Their Role in Infectious Diseases
Lv, L., Jiang, H., Ren, Y., & Li, L. (2019) · Infectious Microbes & Diseases · doi:10.1097/im9.0000000000000001 · Cited by 29
Characterizing microbiota and metabolomics analysis to identify candidate biomarkers in lung cancer
Liu, B., Li, Y., Suo, L., Zhang, W., Cao, H., Wang, R., Luan, J., Xiaofeng, Y., Dong, L., Wang, W., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1058436 · Cited by 34
“found that desaminotyrosine (DAT), which was a metabolite associated with microbiota, helped the host defend against influenza by positively stimulating type I IFN (15).”
BackgroundGut microbiota in COVID-19: new insights from inside
Zhou, B., Pang, X., Wu, J., Liu, T., Wang, B., & Cao, H. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2201157 · Cited by 31
Kinsella, R. L., Chowdhury, C. S., Smirnov, A., Mreyoud, Y., Kimmey, J. M., Esaulova, E., McKee, S. R., Pride, A. C., Kreamalmeyer, D., Artyomov, M. N., et al. (2025) · Nature Microbiology · doi:10.1038/s41564-025-01988-8 · Cited by 29
Self-citationBibliometric analysis of intestinal microbiota and lung diseases
Sun, W., Zhou, T., Ding, P., Guo, L., Zhou, X., & Long, K. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1347110 · Cited by 26
Norovirus interactions with the commensal microbiota
Sullender, M. E., & Baldridge, M. T. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007183 · Cited by 26
Effects of Eclipta prostrata on gut microbiota of SAMP6 mice with osteoporosis
Zhao, X., Ai, J.-Q., Mao, H., & Gao, X. (2019) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000936 · Cited by 26
Network pharmacology to dissect the mechanisms of Yinlai Decoction for pneumonia
Xu, J., Bai, C., Huang, L., Liu, T., Wan, Y., Zheng, Z., Ma, X., Gao, F., Yu, H., & Gu, X. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-02954-z · Cited by 26
Vancomycin use and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation
Zhang, S., Shanley, R., Weisdorf, D. J., & Rashidi, A. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001984 · Cited by 25
The gut-lung axis in COPD: immunomodulatory roles of gut microbiota and novel therapeutic strategies
Ni, F.-X., Wang, H.-X., Hu, J., Chen, P.-S., Xu, P., Chen, H.-H., Ze-Bo, J., & Huang, D.-H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1733726 · Cited by 25
Gao, M., Liao, C., Fu, J., Zhonghua, N., Lv, Z., & Guo, Y. (2024) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-023-00974-6 · Cited by 25
“Recent findings show that Flavonifractor converts flavonoids into dihydrocaffeic acid (DAT), contributing to host protection against influenza [58].”
BackgroundMénage à trois: Virus, Host, and Microbiota in Experimental Infection Models
Mazel‐Sanchez, B., Yildiz, S., & Schmolke, M. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2018.12.004 · Cited by 29
“Baldridge and colleagues showed that interferon lambda (IFNλ) signaling is required for the ABX treatment effect [32, 33].”
InfluentialDing, Y., & Yu, Y. (2025) · Molecular Medicine Reports · doi:10.3892/mmr.2025.13474 · Cited by 25
“There are two key metabolic pathways: i) oxidation reaction and ii) glucuronidation, methylation and sulfation reaction (143,144). oxidation reaction in phase i metabolism is carried out by the cytochrome P450 enzyme system.”
Gut microbiota and tuberculosis infection: interaction and therapeutic potential
Chai, Y., Li, M., Deng, X., Ma, C., Zhou, N., Chen, Y., Yao, Y., Li, K. C., Gong, W., & Lei, H. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2531201 · Cited by 27
“146 Thus, the gut-lung axis is a complex, multifaceted system involving interactions among immune cells, microbial communities, and signaling molecules from both systems.”
Goulding, D. R., Myers, P., Dickerson, A. B., Comins, M. M., Wiltshire, R. A., & Blankenship-Paris, T. L. (2021) · Comparative Medicine · doi:10.30802/aalas-cm-21-000023 · Cited by 24
Hou, C., Liu, W., Liang, Z., Han, W., Li, J., Ye, L., Liu, M., Cai, Z., Zhao, J., Chen, Y., et al. (2018) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2018.02.062 · Cited by 24
A Modern-World View of Host–Microbiota–Pathogen Interactions
Tan, C. Y., Ramirez, Z. E., & Surana, N. K. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100215 · Cited by 24
Reyman, M., Clerc, M., van Houten, M. A., Arp, K., Chu, M. L. J. N., Hasrat, R., Sanders, E. A. M., & Bogaert, D. (2021) · Communications Biology · doi:10.1038/s42003-021-02755-1 · Cited by 25
Microbiota-Dependent Regulation of Antimicrobial Immunity in the Lung
Maschirow, L., Suttorp, N., & Opitz, B. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0101tr · Cited by 25
Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential
Xiang, H., & Liu, Q. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i47.6689 · Cited by 24
Prophylactic effects of probiotics on respiratory viruses including COVID-19: a review
Lee, N., & Paik, H. (2021) · Food Science and Biotechnology · doi:10.1007/s10068-021-00913-z · Cited by 28
“…Findings References Influenza virus Increase in IFN-I levels in lung/production of desaminotyrosine by gut microbe Clostridium orbiscindens Steed et al. (2017) Influenza virus (H1N1) Gut microbiome increased anti-inflammatory cytokine (IL-10 and IL-14) levels in H1N1 infection Rosshart et…”
BackgroundSilva, F., Enaud, R., Creissen, E., Henao-Tamayo, M. I., Delhaès, L., & Izzo, A. A. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01693-21 · Cited by 24
“experiments, possible bidirectional gut–lung communications may include (i) direct migration of innate lymphoid and Th17 cells (70, 71), (ii) elicitation of lung Interferon through the microbial metabolite desamirotyrosine produced in the intestine (72), and (iii) development of immune cells in the bone marrow through…”
BackgroundGut Microbiota–Related Biomarkers in Immuno-Oncology
Silva, C. A. C., Fidelle, M., Almonte, A. A., Derosa, L., & Zitvogel, L. (2025) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-061124-102218 · Cited by 22
People are an organic unity: Gut-lung axis and pneumonia
Guo, J., Wang, L., Han, N., Yuan, C., Yin, Y., Wang, T., Sun, J., Jin, P., Liu, Y., & Jia, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27822 · Cited by 26
“DAT can protect the host from virus infection by promoting the effect of IFN-1 and reducing the lung immunopathology to protect the host against influenza [69].”
BackgroundMohan, A., Mahadevan, G. D., Iyer, V. A., Mukherjee, T. K., Patel, V. H., Kumar, R., Siddiqui, N. M., Nayak, M., Maurya, P. K., & Kumar, P. (2025) · Food Chemistry · doi:10.1016/j.foodchem.2025.144674 · Cited by 24
Wang, Z., Yu, J., Liu, Y., Gong, J., Hu, Z., & Liu, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1636876 · Cited by 28
Göttert, S., Orberg, E. T., Fan, K., Heinrich, P., Matthe, D. M., Khalid, O., Klostermeier, L., Suriano, C., Strieder, N., Gebhard, C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65180-6 · Cited by 24
“DAT had only minor effects on human APCs, aligning with previous reports that DAT promotes APC activation only incombination with viral co-stimulation but not on its own 32,33 .”
InfluentialThe microbiome and rodent models of immune mediated diseases
Hansen, A. K., & Hansen, C. H. F. (2021) · Mammalian Genome · doi:10.1007/s00335-021-09866-4 · Cited by 25
“2011), while it alleviates severity for some respiratory infections, such as human influenza virus (Ichinohe et al. 2011; Steed et al. 2017; Wu et al. 2013), Streptococcus pneumonia (Brown et al.”
BackgroundWatzenboeck, M. L., Drobits, B., Zahalka, S., Gorki, A.-D., Farhat, A., Quattrone, F., Hladik, A., Lakovits, K., Richard, G. M., Lederer, T., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009487 · Cited by 23
“Additionally, microbial metabolites such as desaminotyrosine and short-chain fatty acids were discovered to regulate antiviral immunity and to protect from influenza associated disease morbidity [39,40].”
BackgroundHazan, G., Eubanks, A., Gierasch, C. M., Atkinson, J. J., Fox, C., Hernandez-Leyva, A. J., Rosen, A. L., Kau, A. L., Agapov, E. V., Alexander‐Brett, J. M., et al. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2101094 · Cited by 22
Self-citationWilson, K. R., Gressier, E., McConville, M. J., & Bedoui, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.897462 · Cited by 23
Impact of the Microbiota on Viral Infections
Campbell, D. E., Li, Y., Ingle, H., & Baldridge, M. T. (2023) · Annual Review of Virology · doi:10.1146/annurev-virology-111821-115754 · Cited by 23
Virus Infection Is an Instigator of Intestinal Dysbiosis Leading to Type 1 Diabetes
Morse, Z. J., & Horwitz, M. S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.751337 · Cited by 28
Roles and Mechanisms of NLRP3 in Influenza Viral Infection
Niu, J., & Meng, G. (2023) · Viruses · doi:10.3390/v15061339 · Cited by 22
“Furthermore, the microbial metabolite DAT, produced by Clostridium orbiscindens, combats IAV infection by amplifying IFN-I signaling [155].”
BackgroundLi, L., Shao, X., Feng, Z., Ni, W., He, J., Gong, X., & Xiao, G. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.103579 · Cited by 22
How host metabolism impacts on virus pathogenesis
Varanasi, S. K., & Rouse, B. T. (2017) · Current Opinion in Virology · doi:10.1016/j.coviro.2017.11.003 · Cited by 21
Real-Time Monitoring of Host–Gut Microbial Interspecies Interaction in Anticancer Drug Metabolism
Nguyen, T. T. M., Mai, V.-H., Kim, H. S., Kim, D., Seo, M., An, Y. J., & Park, S. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.1c10998 · Cited by 22
Qiu, J., Shi, C., Zhang, Y., Niu, T., Chen, S., Yang, G., Zhu, S., & Wang, C. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2401649 · Cited by 22
“14 Zhang and colleagues reported that Bifidobacterium animalis mediates a protective effect against avian influenza virus H7N9 by promoting type I and II IFN responses and ameliorating proinflammatory cytokines in the lung of infected mice through the biosynthesis of valine and CoA.”
BackgroundThe microbiota metabolite, phloroglucinol, confers long-term protection against inflammation
Castelo, J., Araujo‐Aris, S., Barriales, D., Pasco, S. T., Seoane, I., Peña‐Cearra, A., Palacios, A., Simó, C., García‐Cañas, V., Khamwong, M., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2438829 · Cited by 23
Li, Z., Dong, L., Zhao, C. G., Zhang, F., Zhao, S., Zhan, J., Li, J., & Li, L. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c03481 · Cited by 20
Probiotics: A gut response to the COVID-19 pandemic but what does the evidence show?
Brahma, S., Naik, A. S., & Lordan, R. (2022) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2022.08.023 · Cited by 22
Gao, Y., Liang, Z., Mao, B., Zheng, X., Shan, J., Jin, C., Liu, S., Kolliputi, N., Chen, Y., Xu, F., et al. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.06.008 · Cited by 20
“It has been demonstrated that the integrity of intestinal commensal bacteria is indispensable for the maturation of the pulmonary immune system and the development of an anti-viral response, and disturbance of gut microbiota causes pathogenic inflammation, even lethal pneumonia [19,20].”
GlcNac produced by the gut microbiome enhances host influenza resistance by modulating NK cells
Hu, X., Sun, X., Zhao, Y., Iv, C., Sun, X., Jin, M., & Zhang, Q. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2271620 · Cited by 21
“Specific intestinal metabolites, such as short-chain fatty acids, 41 deaminotyrosine, 40 and CoA, 39 exert anti-influenza effects through different mechanisms.”
BackgroundSOD3 suppresses early cellular immune responses to parasite infection
Li, Q., Lv, K., Jiang, N., Liu, T., Hou, N., Yu, L., Yang, Y., Feng, A., Zhang, Y., Su, Z., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49348-0 · Cited by 21
Jiang, L., Bai, C., Zhu, J., Chen, S., Wang, Y., Liu, H., Li, Q., Qin, X., Gu, X., & Liu, T. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1404021 · Cited by 20
“Clostridium orbiscindens , as a speci fi c species within the genus Clostridium , produces desaminotyrosine and protects against in fl uenza by enhancing type I interferon signaling and reducing lung immunopathology (Steed et al., 2017).”
Čierniková, S., Ševčíková, A., Novisedláková, M., & Mego, M. (2024) · Cancers · doi:10.3390/cancers16244271 · Cited by 24
“This metabolite, derived from Clostridium orbiscindens , enhances IFN-I signaling [71], subsequently activating immune responses within the TME to promote tumor suppression.”
Zhang, Y., Si, L., Shu, X., Qiu, C., Wan, X., Li, H., Ma, S.-J., Jin, X., Wei, Z., & Hu, H. (2025) · Microbiome · doi:10.1186/s40168-025-02092-z · Cited by 19
“Metabo-lites such as tyrosine, secreted by gut microbiota, induce the production of type I interferons and inflam-masome-dependent cytokines, thereby providing protection against influenza [21].”
Abiead, Y. E., Mohanty, I., Xing, S., Rutz, A., Charron‐Lamoureux, V., Damiani, T., Lu, W., Patti, G. J., Zamboni, N., Yanes, Ó., et al. (2025) · JACS Au · doi:10.1021/jacsau.5c01063 · Cited by 23
Recent advances and prospects in naringin nanocarrier drug delivery system for cancer management
Deshmukh, R., Prajapati, M. K., & Harwansh, R. K. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.105182 · Cited by 21
Naik, S. K., McNehlan, M. E., Mreyoud, Y., Kinsella, R. L., Smirnov, A., Chowdhury, C. S., McKee, S. R., Dubey, N., Woodson, R., Kreamalmeyer, D., et al. (2024) · Mucosal Immunology · doi:10.1016/j.mucimm.2024.07.002 · Cited by 20
Ma, Y., Su, X., & Lü, F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01805 · Cited by 21
“Clostridium orbiscindens produced desaminotyrosine that primes the amplification loop of IFN-I signaling to protect the host (62).”
BackgroundSymptomatology and microbiology of the gastrointestinal tract in post‐COVID conditions
Masir, M. N., & Shirvaliloo, M. (2022) · JGH Open · doi:10.1002/jgh3.12811 · Cited by 22
Celorrio, M., Shumilov, K., Ni, A., Ayerra, L., Self, W. K., de Francisca, N. L. V., Rodgers, R., Schriefer, L. A., Garcia, B., Aymerich, M. S., et al. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115349 · Cited by 19
“…for 7 consecutive days in the drinking water consisting of 250 mg vancomycin, 500 mg neomycin sulfate, 500 mg ampicillin, 500 mg metronidazole (VNAM), and 20 g grape-flavored Kool-Aid (Kraft Heinz, Chicago, IL) in 500 mL of sterile-filtered water (Steed et al., 2017) right after injury.”
Yakabe, K., Uchiyama, J., Akiyama, M., & Kim, Y. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020163 · Cited by 18
The gut microbiota of bats confers tolerance to influenza virus (H1N1) infection in mice
Liu, B., Chen, X., Zhou, L., Li, J., Wang, D., Yang, W., Wu, H., Yao, J., Yang, G., Wang, C., et al. (2022) · Transboundary and Emerging Diseases · doi:10.1111/tbed.14478 · Cited by 20
Yin, L., Liu, X., Yao, Y., Yuan, M., Luo, Y. M., Zhang, G., Pu, J., & Liu, P. (2024) · Journal of Virology · doi:10.1128/jvi.01377-23 · Cited by 20
Smits, H. H., & Jochems, S. P. (2024) · European Respiratory Review · doi:10.1183/16000617.0266-2023 · Cited by 20
“In addition, the flavonoid-derived metabolite desaminotyrosine reduced lung pathology in antibiotic-treated mice prior to influenza infection [194].”
BackgroundMicrobiota as a potentially-modifiable factor influencing COVID-19
Ngo, V. L., & Gewirtz, A. T. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.04.005 · Cited by 18
“SCFAs are well known for regulating the immune response [33,35,52].”
Rajeev, R., Seethalakshmi, P. S., Jena, P. K., Prathiviraj, R., Kiran, G. S., & Selvin, J. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1916429 · Cited by 18
“…in TNF expression in TLR-2 agonist activated human monocytoid cells Thomas, et al. (2016) Desaminotyrosine Clostridium orbiscindens Influenza Lowered immunopathology of lungs and enhanced type I interferon signaling Steed et al. (2017) and liver (Tang, Li, and Hazen 2019; Sayin, et al. 2013).”
BackgroundCircadian Rhythm Modulation of Microbes During Health and Infection
Pearson, J. A., Voisey, A., Boest-Bjerg, K., Wong, F. S., & Li, W. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.721004 · Cited by 20
Modulated Gut Microbiota for Potential COVID-19 Prevention and Treatment
Zhao, S., Feng, P., Meng, W., Jin, W., Li, X., & Li, X. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.811176 · Cited by 20
Wu, Z., & Wang, H. X. (2018) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-018-0033-4 · Cited by 22
“The metabolite of Clostridium difficile-deamino tyrosine (DAT) protects the host from influenza by activating the amplifying loop of type I interferon signal [63].”
BackgroundMetabolomics analysis provides new insights into the medicinal value of flavonoids in tobacco leaves
Hu, Z., Pan, Z., Yang, L., Wang, K., Yang, P., Xu, Z., & Yu, H. (2021) · Molecular Omics · doi:10.1039/d1mo00092f · Cited by 20
How Does Epstein–Barr Virus Interact With Other Microbiomes in EBV-Driven Cancers?
Wen, Y., Xu, H., Han, J., Jin, R., & Chen, H. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.852066 · Cited by 19
“found that oral administration of the human-associated commensal gut bacteria Clostridium orbiscendens or its production, desaminotyrosine (DAT), could protect mice from lethal IAV infection through reduced immunopathology in the lung in a phagocyte-dependent process potentially through augmentation of the Type I IFN…”
BackgroundExact hypothesis testing for shrinkage-based Gaussian graphical models
Bernal, V., Bischoff, R., Guryev, V., Grzegorczyk, M. A., & Horvatovich, P. L. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz357 · Cited by 19
Misra, B. B. (2020) · Biological Research For Nursing · doi:10.1177/1099800420903083 · Cited by 19
Wang, J., Tan, H., Ye, Z., Weng, S., Shi, Y., Xu, J., Liu, H., Li, J., Huang, L., Zhai, L., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2518338 · Cited by 17
“18 Emerging evidence highlights microbial capacity to metabolize dietary phenolics, such as lignans and polyphenols, into bioactive compounds that critically modulate intestinal immune responses.”
Favero, F., Barberis, E., Gagliardi, M., Espinoza, S., Contu, L., Gustincich, S., Boccafoschi, F., Borsotti, C., Lim, D., Rubino, V., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273036 · Cited by 19
Metadata
- Authors
- Steed, A. L., Christophi, G. P., Kaiko, G. E., Sun, L., Goodwin, V. M., Jain, U., Esaulova, E., Artyomov, M. N., Morales, D. J., Holtzman, M. J., Boon, A. C. M., Lenschow, D. J., & Stappenbeck, T. S.
- Affiliations
- Washington University in St. Louis (US)
- ITMO University (RU)
- Corresponding author
- Stappenbeck, Thaddeus S.
- ORCID
- Venue
- Science
- Published
- 2017-08-04
- Volume
- 357
- Issue
- 6350
- Pages
- 498-502
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5753406
- OpenAlex
- W2743370588
- Cited by
- 569
- References
- 55
- Citations by year
- 2026: 40 · 2025: 59 · 2024: 68 · 2023: 74 · 2022: 80 · 2021: 94 · 2020: 78 · 2019: 37 · 2018: 29 · 2017: 8
- FWCI
- 19.02
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Crohn’s Colitis (award312855)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Keywords
- influenza, type I interferon, gut microbiota, microbial metabolites, plant flavonoids, Clostridium, antibiotic-induced dysbiosis, antiviral immunity, phagocytes, inflammation, plant-based diet
- MeSH terms
- Gastrointestinal Microbiome, Animals, Cell Line, Clostridium perfringens, Interferon Type I, Lung, Orthomyxoviridae Infections, Phenylpropionates, Signal Transduction, Mice, Knockout, GTP-Binding Proteins, Mice, Host-Pathogen Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.